Literature DB >> 19252310

The pH-dependent formation of PEGylated bovine lactoferrin by branched polyethylene glycol (PEG)-N-hydroxysuccinimide (NHS) active esters.

Yasuhiro Nojima1, Kazuma Iguchi, Yosuke Suzuki, Atsushi Sato.   

Abstract

PEGylation is an established method for improving the pharmacokinetic properties and pharmacodynamic effects of therapeutic proteins. Amino conjugation by N-hydroxysuccinimide activated polyethylene glycol (PEG-NHS) represents the most common modification of the target proteins. In this study, we compared the reaction velocities of pH-dependent preparations of bovine lactoferrin modified with branched PEG-NHS conducted at pH 7.4 to pH 9.0. PEGylation reaction rates were dependent on pH value, but not on PEG molecular mass. At pH 7.4, reactions advanced gradually and reached steady state by 2 h, whereas at pH 9.0, reactions advanced very quickly and reached steady state within 10 min. Hydrolysis half-life of PEG-NHS exceeded 120 min at pH 7.4, but was below 9 min at pH 9.0. Thus, the pH value is one of the most important factors to obtain the optimal condition for PEGylation by NHS esters.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19252310     DOI: 10.1248/bpb.32.523

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  8 in total

1.  Novel comb-shaped PEG modification enhances the osteoclastic inhibitory effect and bone delivery of osteoprotegerin after intravenous administration in ovariectomized rats.

Authors:  Yoshihiro Miyaji; Yuji Kasuya; Yoshitake Furuta; Atsushi Kurihara; Masayuki Takahashi; Ken-Ichi Ogawara; Takashi Izumi; Osamu Okazaki; Kazutaka Higaki
Journal:  Pharm Res       Date:  2012-06-23       Impact factor: 4.200

2.  Aptamer Recognition of Multiplexed Small-Molecule-Functionalized Substrates.

Authors:  Nako Nakatsuka; Huan H Cao; Stephanie Deshayes; Arin L Melkonian; Andrea M Kasko; Paul S Weiss; Anne M Andrews
Journal:  ACS Appl Mater Interfaces       Date:  2018-07-06       Impact factor: 9.229

3.  Bioactivity and circulation time of PEGylated NELL-1 in mice and the potential for osteoporosis therapy.

Authors:  Yulong Zhang; Omar Velasco; Xinli Zhang; Kang Ting; Chia Soo; Benjamin M Wu
Journal:  Biomaterials       Date:  2014-05-10       Impact factor: 12.479

4.  Synthesis of Mono-PEGylated Growth Hormone Releasing Peptide-2 and Investigation of its Biological Activity.

Authors:  Xiaoyu Hu; Beihua Xu; Ziniu Zhou
Journal:  AAPS PharmSciTech       Date:  2015-03-12       Impact factor: 3.246

5.  Automated Solid-Phase Protein Modification with Integrated Enzymatic Digest for Reaction Validation: Application of a Compartmented Microfluidic Reactor for Rapid Optimization and Analysis of Protein Biotinylation.

Authors:  Regina Fraas; Juliane Diehm; Matthias Franzreb
Journal:  Front Bioeng Biotechnol       Date:  2017-11-13

6.  Antibody conjugation to carboxyl-modified microspheres through N-hydroxysuccinimide chemistry for automated immunoassay applications: A general procedure.

Authors:  Peter Carl; Inês I Ramos; Marcela A Segundo; Rudolf J Schneider
Journal:  PLoS One       Date:  2019-06-26       Impact factor: 3.240

7.  Temporary In Situ Hydrogel Dressings for Colon Polypectomies.

Authors:  Katherine Cook; Nada Naguib; Courtney E Price; Stefan Katharios; Jack Kirsch; Kareen Cortes; Katherine Hohl; George A O'Toole; Mark W Grinstaff
Journal:  ACS Biomater Sci Eng       Date:  2021-08-03

8.  Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice.

Authors:  Jayanth Suryanarayanan Shankaranarayanan; Jagat R Kanwar; Afrah Jalil Abd Al-Juhaishi; Rupinder K Kanwar
Journal:  Sci Rep       Date:  2016-08-31       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.